These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9683957

  • 1. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A, Irkeç M, Orhan M.
    Eye (Lond); 1998; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [Abstract] [Full Text] [Related]

  • 2. Effect of lodoxamide on tear leukotriene levels in giant papillary conjunctivitis associated with ocular prosthesis.
    Akman A, Irkeç M, Orhan M, Erdener U.
    Ocul Immunol Inflamm; 1998 Sep; 6(3):179-84. PubMed ID: 9785608
    [Abstract] [Full Text] [Related]

  • 3. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A, Borghesan F, Avarello A, Plebani M, Secchi AG.
    Br J Ophthalmol; 1997 Jan; 81(1):23-6. PubMed ID: 9135403
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM, Avunduk MC, Kapicioglu Z, Akyol N, Tavli L.
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [Abstract] [Full Text] [Related]

  • 5. Lodoxamide in vernal keratoconjunctivitis.
    Lee S, Allard TR.
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [Abstract] [Full Text] [Related]

  • 6. Tear tryptase in vernal keratoconjunctivitis.
    Tabbara KF.
    Arch Ophthalmol; 2001 Mar; 119(3):338-42. PubMed ID: 11231766
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H, Bitiren M, Aslan OS, Ozardali I.
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [Abstract] [Full Text] [Related]

  • 8. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P, Allewaert R, Joyaux JC, Piozzi E, Koliopoulos J, Bloch-Michel E, Lodoxamide Study Group.
    Eur J Ophthalmol; 2001 Jun; 11(2):120-5. PubMed ID: 11456011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO, Onakoya AO, Olasimbo OO, Adefule AK.
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D, Khan M, Gul A, Alam R.
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological mechanism of topical lodoxamide treatment in vernal keratoconjunctivitis: a flow-cytometric study.
    Avunduk AM, Avunduk MC, Dayanir V, Tekelioğlu Y, Dayioğlu YS.
    Ophthalmic Res; 1998 Mar; 30(1):37-43. PubMed ID: 9483586
    [Abstract] [Full Text] [Related]

  • 13. Comparison of olopatadine and fluorometholone in contact lens-induced papillary conjunctivitis.
    Khurana S, Sharma N, Agarwal T, Chawla B, Velpandian T, Tandon R, Titiyal JS.
    Eye Contact Lens; 2010 Jul; 36(4):210-4. PubMed ID: 20531202
    [Abstract] [Full Text] [Related]

  • 14. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
    Oray M, Toker E.
    Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
    [Abstract] [Full Text] [Related]

  • 15. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis.
    Leonardi A, Borghesan F, DePaoli M, Plebani M, Secchi AG.
    Exp Eye Res; 1998 Jul; 67(1):105-12. PubMed ID: 9702183
    [Abstract] [Full Text] [Related]

  • 16. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo.
    Zailaie MZ.
    Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I, Gabrić N, Lazić R, Bosnar D, Cima I, Stipić A.
    Acta Med Croatica; 2002 Oct; 56(3):93-8. PubMed ID: 12630339
    [Abstract] [Full Text] [Related]

  • 18. Stem cell factor in the tear fluid of vernal keratoconjunctivitis patients.
    Nakatani S, Ebihara N, Murakami A.
    Jpn J Ophthalmol; 2007 Oct; 51(6):474-6. PubMed ID: 18158601
    [Abstract] [Full Text] [Related]

  • 19. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F, Gangemi S, Ricciardi L, Cuzzocrea S, Di Lorenzo G.
    Allergol Immunopathol (Madr); 1997 Oct; 25(5):233-7. PubMed ID: 9395007
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR, Verin P, Hartwich-Young R, Meyer SM, Drake MM.
    Am J Ophthalmol; 1992 Jun 15; 113(6):632-7. PubMed ID: 1598953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.